Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: C
Results 1 - 10 of 958 shown below

  • c- erb B-4

    T Y Kew, J A Bell, S E Pinder, H Denley, R Srinivasan, W J Gullick, R I Nicholson, R W Blamey and I O Ellis

    c- erb B-4 protein expression in human breast cancer

    doi:10.1054/bjoc.1999.1057

    Abstract | Full article | PDF

  • c- fos

    I Chatzistamou, A V Schally, B Sun, P Armatis and K Szepeshazi

    Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists

    doi:10.1054/bjoc.2000.1374

    Abstract | Full article | PDF

  • c- jun

    I Chatzistamou, A V Schally, B Sun, P Armatis and K Szepeshazi

    Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists

    doi:10.1054/bjoc.2000.1374

    Abstract | Full article | PDF

  • c- jun N-terminal kinase-1

    B Liu, M Fang, M Schmidt, Y Lu, J Mendelsohn and Z Fan

    Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c- jun N-terminal kinase activity

    doi:10.1054/bjoc.2000.1201

    Abstract | Full article | PDF

  • c-Abl

    A Nehmé, R Baskaran, S Nebel, D Fink and R D Christen

    Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells

    doi:10.1038/sj.bjc.6690176

    Abstract | Full article | PDF

  • c-Abl tyrosine kinase

    A Nehmé, B L Lee, R Baskaran, Q Zhang, X Lin and R D Christen

    Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage

    doi:10.1054/bjoc.2000.1440

    Abstract | Full article | PDF

  • C-cell hyperplasia

    A Bounacer, J A Du Villard, R Wicker, B Caillou, M Schlumberger, A Sarasin and H G Suárez

    Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue

    doi:10.1038/sj.bjc.6600371

    Abstract | Full article | PDF

  • c-erb A-alpha2 (TR-alpha2)

    J-W Lee, C-L Chen, B-T Juang, J-Y Chen, C-S Yang and S-L Doong

    Elevated expression of thyroid hormone receptor alpha 2 (c-erb A- alpha 2) in nasopharyngeal carcinoma*

    doi:10.1054/bjoc.2000.1505

    Abstract | Full article | PDF

  • c-erbB-2

    J A McKay, J F Loane, V G Ross, M-M Ameyaw, G I Murray, J Cassidy and H L McLeod

    c-erbB-2 is not a major factor in the development of colorectal cancer

    doi:10.1038/sj.bjc.6600127

    Abstract | Full article | PDF

  • M I Koukourakis, A Giatromanolaki, G Galazios and E Sivridis

    Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?

    doi:10.1038/sj.bjc.6600755

    Abstract | Full article | PDF

  • C I Li, K E Malone, P L Porter and J R Daling

    Epidemiologic and molecular risk factors for contralateral breast cancer among young women

    doi:10.1038/sj.bjc.6601042

    Abstract | Full article | PDF

  • Y Katterle, B H Brandt, S F Dowdy, B Niggemann, K S Zänker and T Dittmar

    Antitumour effects of PLC-italic gamma1-(SH2)2-TAT fusion proteins on EGFR/c-erbB-2-positive breast cancer cells

    doi:10.1038/sj.bjc.6601506

    Abstract | Full article | PDF

  • P M Schneider, H W Praeuer, O Stoeltzing, J Boehm, J Manning, R Metzger, U Fink, S Wegerer, A H Hoelscher and J A Roth

    Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer

    doi:10.1054/bjoc.2000.1287

    Abstract | Full article | PDF

  • Y Ito, T Takeda, M Sakon, M Tsujimoto, S Higashiyama, K Noda, E Miyoshi, M Monden and N Matsuura

    Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

    doi:10.1054/bjoc.2000.1580

    Abstract | Full article | PDF

  • A Scorilas, T Trangas, J Yotis, C Pateras and M Talieri

    Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis

    doi:10.1038/sj.bjc.6693404

    Abstract | Full article | PDF

  • c-erbB-2 oncogene

    K Wiechen, S Karaaslan, A Turzynski and M Dietel

    Suppression of the c-erbB-2 gene product decreases transformation abilities but not the proliferation and secretion of proteases of SK-OV-3 ovarian cancer cells

    doi:10.1038/sj.bjc.6690765

    Abstract | Full article | PDF